Recent evidence has shown that in several neurodegenerative diseases, including Alzheimer's disease (AD), the expression level and function of p300/CBP are severely compromised, leading to altered gene expression causing pathological conditions. The gene discussed is EP300; the disease is early-onset autosomal dominant Alzheimer disease.